Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Clinical Trial Results: What the Data Shows Semaglutide has been evaluated in the STEP (Semaglutide Treatment Effect in People with obesity) trial program, which included four major studies of semaglutide 2.4 mg weekly across different patient populations, including adults with obesity, adults with type 2 diabetes, and adults receiving intensive behavioral support alongside the medication
and F.M.G.s work was funded by Wellcome (220271/Z/20/Z) and the MRC (MRC_MC_UU_12012/3)
How you see yourself
At the studys conclusion, patients from both groups demonstrated statistically significant improvement
US$ 26.58
US$ 29.83
US$ 20.18
US$ 29.80
US$ 28.51
US$ 25.87
